Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « ISSN » - entrée « 0013-7006 »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
0006-3207 < 0013-7006 < 0020-5346  Facettes :

List of bibliographic references indexed by 0013-7006

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000082 (2020) N. Bouaziz [France] ; H. Ben Rejeb [France] ; S. Ateb [France] ; T. Fourati [France] ; F. Chammas [France] ; D. Baha [France] ; R. Rosetti [France] ; K. Kalalou [France] ; G. Saba [France] ; R. Benadhira [France] ; D. Januel [France][Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate].
000089 (2020) S. Hartley [France] ; C. Colas Des Francs [France] ; F. Aussert [France] ; C. Martinot [France] ; S. Dagneaux [France] ; V. Londe [France] ; L. Waldron [France] ; S. Royant-Parola [France][The effects of quarantine for SARS-CoV-2 on sleep: An online survey].
000096 (2020) I. Conejero [France] ; S. Berrouiguet [France] ; D. Ducasse [France] ; M. Leboyer [France] ; V. Jardon [France] ; E. Olié [France] ; P. Courtet [France][Suicidal behavior in light of COVID-19 outbreak: Clinical challenges and treatment perspectives].
000109 (2020) R. Bocher [France] ; C. Jansen [France] ; P. Gayet [France] ; P. Gorwood [France] ; V. Laprévote [France][Responsiveness and sustainability of psychiatric care in France during COVID-19 epidemic].
000111 (2020) M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France][Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
000115 (2020) A. Sauvaget [France] ; R. Dumont [France] ; N. Bukowski [France] ; O. Bonnot [France] ; R. Auffret [France] ; E. Poulet [France] ; D. Szekely [France] ; C. Quiles [France] ; A. Yrondi [France] ; M. Plaze [France] ; W. De Carvalho [France] ; A. Amad [France] ; S. Bulteau [France][Recommendations for a gradual and controlled resumption of electroconvulsive therapy in France during the period of lifting of the containment and of the COVID-19 pandemic linked to SARS-CoV-2].
000117 (2020) L. Boyer [France] ; P. Auquier [France] ; G. Fond [France][Real-life data and Covid-19: The third avenue of reseach].
000119 (2020) A. Mengin [France] ; M C Allé [Danemark] ; J. Rolling [France] ; F. Ligier [France] ; C. Schroder [France] ; L. Lalanne [France] ; F. Berna [France] ; R. Jardri [France] ; G. Vaiva [France] ; P A Geoffroy [France] ; P. Brunault [France] ; F. Thibaut [France] ; A. Chevance [France] ; A. Giersch [France][Psychopathological consequences of confinement].
000129 (2020) H. Javelot [France] ; L. Weiner [France][Panic and pandemic: Review of the literature on the links between panic disorder and the SARS-CoV-2 epidemic].
000141 (2020) T. Fovet [France] ; C. Lancelevée [France] ; M. Eck [France] ; T. Scouflaire [France] ; E. Bécache [France] ; D. Dandelot [France] ; P. Giravalli [France] ; A. Guillard [France] ; P. Horrach [France] ; M. Lacambre [France] ; T. Lefebvre [France] ; A-H Moncany [France] ; D. Touitou [France] ; M. David [France] ; P. Thomas [France][Mental health care in French correctional facilities during the Covid-19 pandemic].
000152 (2020) H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France][Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
000155 (2020) J. Daaboul [France] ; R. Tamouza [France] ; M. Leboyer [France][Immunopsychiatry and SARS-CoV-2 pandemic: Links and possible consequences].
000164 (2020) E. Bobo [France] ; L. Lin [France] ; E. Acquaviva [France] ; H. Caci [France] ; N. Franc [France] ; L. Gamon [France] ; M-C Picot [France] ; F. Pupier [France] ; M. Speranza [France] ; B. Falissard [France] ; D. Purper-Ouakil [France][How do children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) experience lockdown during the COVID-19 outbreak?]
000166 (2020) W. El-Hage [France] ; C. Hingray [France] ; C. Lemogne [France] ; A. Yrondi [France] ; P. Brunault [France] ; T. Bienvenu [France] ; B. Etain [France] ; C. Paquet [France] ; B. Gohier [France] ; D. Bennabi [France] ; P. Birmes [France] ; A. Sauvaget [France] ; E. Fakra [France] ; N. Prieto [France] ; S. Bulteau [France] ; P. Vidailhet [France] ; V. Camus [France] ; M. Leboyer [France] ; M-O Krebs [France] ; B. Aouizerate [France][Health professionals facing the coronavirus disease 2019 (COVID-19) pandemic: What are the mental health risks?]
000172 (2020) M. Masson [France] ; R. Gaillard [France][French psychiatry and the novelty of the COVID-19 crisis].
000178 (2020) A. Amad [France] ; M. Magnat [France] ; C. Quilès [France] ; A. Yrondi [France] ; A. Sauvaget [France] ; S. Bulteau [France] ; M. Plaze [France] ; M. Rotharmel [France] ; M. Polosan [France] ; D. Lévy-Chavagnat [France] ; N. Jaafari [France] ; G. Vaiva [France] ; P. Thomas [France][Evolution of electro-convulsive therapy activity in France since the beginning of the COVID-19 pandemic].
000180 (2020) A. Chevance [France] ; D. Gourion [France] ; N. Hoertel [France] ; P-M Llorca [France] ; P. Thomas [France] ; R. Bocher [France] ; M-R Moro [France] ; V. Laprévote [France] ; A. Benyamina [France] ; P. Fossati [France] ; M. Masson [France] ; E. Leaune [France] ; M. Leboyer [France] ; R. Gaillard [France][Ensuring mental health care during the SARS-CoV-2 epidemic in France: A narrative review].
000182 (2020) M. Thépaut [France] ; S. Ferracci [France] ; I. Dormois [France] ; F. Haour [France] ; N. Cazenave [France][Early EMDR defusing in a COVID-19 testing center].
000189 (2020) H. Bottemanne [France] ; O. Morlaàs [France] ; L. Schmidt [France] ; P. Fossati [France][Coronavirus: Predictive brain and terror management].
000191 (2020) A. Ben Dhia [France] ; S. Hamzaoui [France] ; F. Mouaffak [France][Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?]
000195 (2020) H. Javelot [France] ; P-M Llorca [France] ; G. Meyer [France] ; P. Fossati [France] ; E. Haffen [France][Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "0013-7006" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "0013-7006" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    0013-7006
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021